AI summary · may contain errors
Blood Cancer United acquired the remaining supply of luveltamab tazevibulin and will keep a compassionate use program for children with a rare form of AML.
- In the news
Moving in Cancer Discovery.
Rebuilt
AI summary · may contain errors
Blood Cancer United acquired the remaining supply of luveltamab tazevibulin and will keep a compassionate use program for children with a rare form of AML.
Newest first · last 60 days
AI summary · may contain errors
Across German online marketplaces (March 2025–May 2026), 282 commercial electric breast pump models from 108 brands ranged from 19.99 to 659.57 EUR, with a median of 72.70 EUR.
AI summary · may contain errors
In fee-for-service Medicare patients with incident cancer (2014–2020), oncologists’ guideline-preferred drug payments were linked to higher receipt of preferred treatment (RR=1.06).
AI summary · may contain errors
Dialog-driven regulatory initiatives by Japan’s Pharmaceuticals and Medical Devices Agency for live biotherapeutic products, fecal microbiota transplantation, and phage therapy medicinal products are highlighted as a key approach.
AI summary · may contain errors
Medicare Advantage beneficiaries receiving intravitreal anti-VEGF therapy used higher-cost drugs less often than Medicare Fee-For-Service, with aflibercept 2 mg lower by 7.7%.
AI summary · may contain errors
By 2026, 29 states and Washington, DC, enacted insulin out-of-pocket caps, covering an estimated 0.99 million adults with diabetes using insulin in state-regulated commercial plans.
AI summary · may contain errors
The Therapeutic Goods Administration (TGA) is positioned to shift regulatory effort earlier in the medical device lifecycle, enabling more timely Australian access to MedTech innovation.
AI summary · may contain errors
Compounded GLP-1 weight-loss prescriptions show distinct dispensing patterns, including self-payment rates, out-of-state dispensing, and specific ingredient coformulations identified from prescription monitoring data.
AI summary · may contain errors
The best spatiotemporal model estimates that substandard and falsified antimalarial prevalence peaked between 1996 and 2003, with higher predictions in West and Central Africa (WAIC=499.430).
AI summary · may contain errors
A validated global consensus for schizophrenia in Ethiopia, Nigeria, Rwanda, and South Africa prioritizes antipsychotic drugs and highlights evidence gaps, including limited country-specific trials.
AI summary · may contain errors
Biosimilar entry for bevacizumab, rituximab, and trastuzumab in US oncology is linked to a 3.8% annual ASP decline and falling reference market share.
AI summary · may contain errors
FDA decisions on oncology drug trials for refractory melanoma in the US are discussed as potentially harming the regulatory environment for future cancer-drug development.
AI summary · may contain errors
In 2022 claims for 12,134 Medicare and commercially insured patients with blood-cancer SOAM prescriptions, only 9.6% (Medicare) and 4.0% (commercial) were approved and filled initially.
Journals this month
Topics moving, week to 17 Nov 2026
By field